Come up with a name for your new list and we'll add to it:
NeoChord raised a round of funding on October 24, 2013. Investors include
Square 1 Bank.
NeoChord is a medical technology company focused on advancing the treatment of mitral regurgitation. The Company expects to commercialize a surgical device for minimally invasive mitral valve repair v…